Premium
A Highly Selective Poly(thiophene)‐graft‐Poly(methacrylamide) Polymer Modified ITO Electrode for Neuron Specific Enolase Detection in Human Serum
Author(s) -
Aydın Muhammet,
Aydın Elif Burcu,
Sezgintürk Mustafa Kemal
Publication year - 2019
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.201900109
Subject(s) - methacrylamide , detection limit , polymer , biosensor , electrode , glutaraldehyde , materials science , polymerization , chemistry , repeatability , linear range , chromatography , nanotechnology , monomer , organic chemistry , acrylamide
In this study, an impedimetric immunosensor based on polymer poly(thiophene)‐graft‐poly(methacrylamide) polymer (P(Thi‐g‐MAm)) modified indium tin oxide (ITO) electrode is developed for the detection of the Neuron Specific Enolase (NSE) cancer biomarker. First, the P(Thi‐g‐MAm) polymer is synthesized and coated on the ITO electrode by using a spin‐coating technique. P(Thi‐g‐MAm) polymer acts as an immobilization platform for immobilization of NSE‐specific monoclonal antibodies. Anti‐NSE antibodies are utilized as biosensing molecules and they bind to the amino groups of P(Thi‐g‐Mam) polymer via glutaraldehyde cross‐linking. Spin‐coating technique is employed for bioelectrode fabrication and this technique provides a thin and uniform film on the ITO electrode surface. This bioelectrode fabrication technique is simple and it generates a suitable platform for large‐scale loadings of anti‐NSE antibodies. This immunosensor exhibits a wide linear detection range from 0.02 to 4 pg mL −1 and with an ultralow detection limit of 6.1 fg mL −1 . It reveals a good long‐term stability (after 8 weeks, 78% of its initial activity), an excellent reproducibility (1.29% of relative standard deviation (RSD)), a good repeatability (5.55% of RSD), and a high selectivity. In addition, the developed immunosensor is proposed as a robust diagnostic tool for the clinical detection of NSE and other cancer biomarkers.